July 20 (Reuters) - Japan's Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making ...

QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing ...

New Delhi [India], July 20 (ANI): Takeda Biopharmaceuticals India Pvt Ltd. today announced that the Drug Controller General ...

India has approved its first dengue vaccine, QDENGA, for individuals aged 4 to 60 years. The DCGI clearance allows ...

India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation ...

Takeda's QDENGA has been approved for people aged 4–60, offering a new prevention tool as dengue cases and the wider disease ...

New Delhi, July 20 (IANS) India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to Takeda Biopharmaceuticals India's QDENGA, ...

The Drug Controller General of India (DCGI) has granted market authorisation to Takeda's QDENGA, the country's first approved dengue vaccine. The vaccine is approved for individuals aged 4 to 60 years ...

QDENGA, the first dengue vaccine approved in India, is used for the prevention of dengue in individuals aged 4-60 years. It ...

India has taken a major step in the fight against dengue after the Central Drugs Standard Control Organisation (CDSCO) approved Takeda's QDENGA (TAK-003), ma ...

New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, ...

Joseph Ours leads the AI Strategy Practice at Centric Consulting. ​Gartner researchers project that 40% of enterprise ...